Adobe agrees to pay $150 million to resolve alleged violations of online shopper law-March 2024-www.financetom.com

Adobe agrees to pay $150 million to resolve alleged violations of online shopper law

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Adobe agrees to pay $150 million to resolve alleged violations of online shopper law

Mar 13, 2026 1:10 PM

March 13 (Reuters) - The U.S. Justice Department said on

Friday that Adobe Inc ( ADBE ) has agreed to a $150 million

settlement and an injunction to resolve allegations that the

software firm's subscription practices violated the Restore

Online Shoppers' Confidence Act.

Previous page： Biogen Completes Acquisition of Alcyone Therapeutics Next page： Market Chatter: Sony Picks Up Film Rights to Labubu Toy Brand

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Biogen Completes Acquisition of Alcyone Therapeutics

Nov 14, 2025

CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. ( BIIB ) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative CNS therapy delivery solutions, such as the ThecaFlex DRx™ drug delivery system. ThecaFlex DRx™ is an investigational implantable device designed to provide an alternative to repeat lumbar punctures in chronic intrathecal administration...

Market Chatter: Sony Picks Up Film Rights to Labubu Toy Brand

Nov 14, 2025

04:01 PM EST, 11/14/2025 (MT Newswires) -- Sony Group ( SONY ) unit Sony Pictures has acquired the screen rights to Labubu, the Chinese plush-toy line, and plans to develop it as a feature film, multiple media outlets reported Friday. The project is in early development with no producers attached, and it is still undecided whether the movie will be...

Sarepta Gains FDA Approval for Updated Safety Guidance on Duchenne Gene Therapy

Nov 14, 2025

04:00 PM EST, 11/14/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) said Friday that the U.S. Food and Drug Administration has approved updated prescribing information for Elevidys, its gene therapy for Duchenne muscular dystrophy. The update adds a boxed warning for acute liver injury and liver failure, expands prescriber guidance with new monitoring requirements, and removes the therapy's non-ambulatory...

Modiv Industrial Announces Third Quarter 2025 Results

Nov 14, 2025

DENVER--(BUSINESS WIRE)-- Modiv Industrial, Inc. ( MDV ) (“Modiv Industrial,” “Modiv” or the “Company”) , the only public REIT exclusively focused on acquiring industrial manufacturing real estate, today announced operating results for the third quarter ended September 30, 2025. The following is a statement from Aaron Halfacre, CEO of Modiv Industrial ( MDV ). “That which is behind us... Third...